Stem cells: therapies for the future? Press conference (18 December)December 14, 2001The European Commission (DG Research), has organised the conference "Stem Cells: Therapies for the Future?" to provide a discussion platform for representatives of society and encourage debate on the multiple issues surrounding recent advances in stem cell research. This initiative was launched under the aegis of the Life Sciences High Level Group (LSHLG) advising Research Commissioner Philippe Busquin. In that context, a press conference is arranged on 18 December with the participation of Commissioner Busquin and members of the LSHLG. Stem cells open the prospect of treatment for a number of diseases and injuries and, at the same time, raise a number of crucial questions. How realistic are these expectations? What are the ethical and social implications? How do we decide whether or not to use this technology? Who can make that decision? The recent Eurobarometer study illustrates the concern of European citizens: 84% agree that a discovery in itself is neither good or bad, what is important is the use that is made of it; 80% concur that authorities ought to formally oblige scientists to observe ethical rules; and 73.5% believe that scientists should be free to pursue their research as they wish as long as they observe ethical rules. Summarising the dilemma, Commissioner Busquin recently said: "Not everything that is scientifically possible and technologically feasible is necessarily desirable or admissible. We must allow for a full, and truly inclusive debate on how to handle such questions with dignity and a sense of responsibility." The conference The aim of the conference is to offer a discussion forum between scientists and the public on the possibilities, priorities and difficulties of stem cell research in Europe. The conference will begin by reviewing recent advances in this area and their medical and ethical consequences. However, its objective is primarily to provide a discussion platform to launch and encourage a pluralistic and informative debate with a wide range of representatives of society concerned by the potential benefits, the possible risks and the ethical implications. Consequently, the Commission has invited a wide range of stakeholders including scientists, experts in ethics, patients` associations, interest groups, the medical profession, the media, members of Parliaments, public authorities and civil society representatives who will all have the opportunity to exchange views in an open debate. The press conference (18/12/01 - 11:15) At the press conference on 18 December, members of the Life Science High Level Group will review the medical, ethical and social impact of advances on stems cell research in the context of the conference, while Commissioner Busquin will comment on recent policy developments (see programme for details). Further information and the conference programme are available on the Web: Press conference programme (18/12/01 - 11:15) Breydel - Press Room- Av. d'Auderghem 45 - 1049 Brussels 11:15 | |||||||||||||||||||||
|
Related Stem Cells Current Events and Stem Cells News Articles Fat injections can improve breast reconstruction -- jury's out on augmentation Injecting fat after breast reconstruction to correct implant wrinkling or dimpling may be safe and effective to improve breast shape. Mayo researchers explore issues related to multiple myeloma treatment Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Reversible 3-D cell culture gel invented Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research. The small cell neuroendocrine carcinoma of the ampulla of vater Ampullary small cell neuroendocrine carcinoma is extremely rare and has only been documented in few case reports and retrospective study. The patients with ampullary small cell neuroendocrine carcinoma usually presented after the age of 60 years, and a male predilection was observed. Researchers Find an Essential Gene for Forming Ears of Corn Cold Spring Harbor Laboratory (CSHL) professor David Jackson, Ph.D., and a team of plant geneticists have identified a gene essential in controlling development of the maize plant, commonly known in the United States as corn. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle. Healthy blood vessels may prevent fat growth The cells lining blood vessels are known to be important for maintaining health, but researchers at the Indiana University School of Medicine believe these cells may perform an unsuspected task - controlling the development of fat cells. UNC scientists turn human skin cells into insulin-producing cells Researchers at the University of North Carolina at Chapel Hill School of Medicine have transformed cells from human skin into cells that produce insulin, the hormone used to treat diabetes. Stem cells may solve mystery of early pregnancy breast cancer protection The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell. Scientists identify genes capable of regulating stem cell function Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders. More Stem Cells Current Events and Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||